BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Abliva
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211130
DTEND;VALUE=DATE:20211203
DTSTAMP:20260406T114901
CREATED:20211111T130531Z
LAST-MODIFIED:20211122T145635Z
UID:2970-1638230400-1638489599@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:Abliva will attend the virtual conference Mitochondrial Medicine – Therapeutic Development\, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK\, on 30 Nov – 2 Dec 2021. \nAbliva’s CMO\, Magnus Hansson\, has been invited to give a presentation on the topic Academia-pharma interplay in drug development\, during Session 1: Mitochondrial Medicine – pharma and funding perspectives.
URL:https://abliva.com/event/mitochondrial-medicine-therapeutic-development/
LOCATION:Virtual
CATEGORIES:Scientific event
END:VEVENT
END:VCALENDAR